Enliven Therapeutics Inc. (ELVN)
NASDAQ: ELVN
· Real-Time Price · USD
20.16
0.39 (1.97%)
At close: Aug 15, 2025, 2:57 PM
Enliven Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for ELVN stock have an median target of 42, with a low estimate of 27 and a high estimate of 52. The median target predicts an increase of 108.33% from the current stock price of 20.16.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 27 | 41.2 | 42 | 52 |
| Change | 33.93% | 104.37% | 108.33% | 157.94% |
Latest Analyst Insight Report
HC Wainwright & Co. has reaffirmed a Buy rating fo... Unlock content with Pro Subscription
Updated Jul 02, 2025
| Rating | Nov 24 | Dec 24 | Mar 25 | May 25 | Jun 25 | Jul 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 0 | 1 |
| Buy | 1 | 1 | 0 | 1 | 2 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 1 |
Financial Forecast this Year
Revenue This Year
7.14K
from 0
Increased by n/a%
Revenue Next Year
7.14K
from 7.14K
Increased by 0.0%
EPS This Year
-2.08
from -1.89
Increased by -10.1%
EPS Next Year
-2.36
from -2.08
Increased by -13.5%